Showing results (1951-1960 of 3,310) with videos related to
Sort By:
Pageof 331
Metabolic Brain Disease|April 27, 2021
RNA as a source of biomarkers for amyotrophic lateral sclerosisLily Kiaei, Mahmoud KiaeiMetabolic Brain Disease|April 26, 2021
Recent advances in pre-clinical diagnosis of Alzheimer's diseaseJohn Zhou, Marc Benoit, Md Golam SharoarMetabolic Brain Disease|April 12, 2021
MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activitiesYaoran Tu, Yong HuMetabolic Brain Disease|May 15, 2023
Valproate-induced murine autism spectrum disorder is associated with dysfunction of amygdala parvalbumin interneurons and downregulation of AMPK/SIRT1/PGC1α signalingElham Zahedi, Seyed Shahabeddin Sadr, Ashkan Sanaeierad, et al.Metabolic Brain Disease|April 19, 2021
LncRNA MYCNOS promotes glioblastoma cell proliferation by regulating miR-216b/FOXM1 axisPing Zhao, Ting Li, Youliang Wang, et al.Metabolic Brain Disease|April 17, 2021
The role of sex-differentiated variations in stress hormones, antioxidants, and neuroimmune responses in relation to social interaction impairment in a rodent model of autismSameera Abuaish, Norah M Al-Otaibi, Kawther Aabed, et al.Metabolic Brain Disease|February 27, 2003
Effects of hyperammonemia and liver failure on glutamatergic neurotransmissionPilar Monfort, María-Dolores Muñoz, Amina ElAyadi, et al.Metabolic Brain Disease|February 27, 2003
Valproate-induced hyperammonemic encephalopathyAlberto Verrotti, Daniela Trotta, Guido Morgese, et al.Metabolic Brain Disease|February 27, 2003
Mild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospectsNicolas Chatauret, Christopher Rose, Roger F ButterworthMetabolic Brain Disease|February 27, 2003
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological dataS Mitzner, J Loock, P Peszynski, et al.Pageof 331